Rethinking the diagnosis of double-seronegative myasthenia gravis

被引：0
|
作者：
Kim, Sohyeon [1 ]
Eun, Mi-Yeon [2 ]
Lee, Jae-Joon [1 ]
Seok, Hung Youl [1 ,3 ]
机构：
[1] Keimyung Univ, Dongsan Hosp, Sch Med, Dept Neurol, Daegu, South Korea
[2] Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Neurol, Daegu, South Korea
[3] Keimyung Univ, Dongsan Hosp, Sch Med, Dept Neurol, 1035 Dalgubeol Daero, Daegu 42601, South Korea
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2024年 / 31卷 / 03期
关键词：
D O I：
10.1111/ene.16151
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Reply to letter in response to Rethinking the diagnosis of double-seronegative myasthenia gravis
    Martinez-Harms, Rodrigo
    Barnett, Carolina
    Alcantara, Monica
    Bril, Vera
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (03)
  • [2] Investigation of the clinical features of double-seronegative myasthenia gravis
    Yutani, S.
    Kawamura, R.
    Netsu, S.
    Mukai, M.
    Nagata, E.
    Takizawa, S.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 914 - 914
  • [3] Clinical characteristics and treatment outcomes in patients with double-seronegative myasthenia gravis
    Martinez-Harms, Rodrigo
    Barnett, Carolina
    Alcantara, Monica
    Bril, Vera
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (01)
  • [4] Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin
    Cortes-Vicente, Elena
    Gallardo, Eduard
    Angeles Martinez, Maria
    Diaz-Manera, Jordi
    Querol, Luis
    Rojas-Garcia, Ricard
    Illa, Isabel
    JAMA NEUROLOGY, 2016, 73 (09) : 1099 - 1104
  • [5] Autoantibodies to Lipoprotein-Related Protein 4 in Patients With Double-Seronegative Myasthenia Gravis
    Zhang, Bin
    Tzartos, John S.
    Belimezi, Maria
    Ragheb, Samia
    Bealmear, Beverly
    Lewis, Richard A.
    Xiong, Wen-Cheng
    Lisak, Robert P.
    Tzartos, Socrates J.
    Mei, Lin
    ARCHIVES OF NEUROLOGY, 2012, 69 (04) : 445 - 451
  • [6] Retrospective analysis of efgartigimod use in patients with double-seronegative generalized myasthenia gravis: a case series
    Horiuchi, Kazuhiro
    Nakamura, Shuntaro
    Yamada, Kazuki
    Inoue, Takashi
    Oiwa, Kei
    NEUROMUSCULAR DISORDERS, 2024, 39 : 37 - 41
  • [7] Nivolumab/pembrolizumabLate-onset double-seronegative myasthenia gravis syndrome with myasthenic crisis and iritis: case report
    Reactions Weekly, 2021, 1881 (1) : 203 - 203
  • [8] Late-onset double-seronegative myasthenia gravis syndrome and myasthenic crisis due to nivolumab use for Hodgkin's lymphoma
    Dang, Thai
    Macwan, Samir
    Dasanu, Constantin A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (06) : 1534 - 1538
  • [9] Seronegative myasthenia gravis
    Vincent, A
    McConville, J
    Farrugia, ME
    Newsom-Davis, J
    SEMINARS IN NEUROLOGY, 2004, 24 (01) : 125 - 133
  • [10] Seronegative myasthenia gravis
    Gajdos, P
    REVUE NEUROLOGIQUE, 2004, 160 (02) : 159 - 162
12345